A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07455851 · RECRUITING
Trial details
- NCT number
- NCT07455851
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-26
- Primary completion
- 2033-09-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.